Podofilox Topical Gel shortage

To Be Discontinued

Podofilox Topical Gel is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category

Dermatology

Dosage form

Topical Gel

Routes

TOPICAL

Last updated

01/28/2026

Strength variants

Not specified

Need sourcing help for Podofilox Topical Gel?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

AbbVie Inc.800-633-9110
To Be Discontinued

Reason for shortage

Not specified

ad slot 300x250

Related shortages in Dermatology

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/08/2026

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/03/2026

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/03/2026

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/03/2026

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/03/2026

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/02/2026

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.